**Core Concept**
The question pertains to the classification and safe usage of contrast agents, specifically those that can be injected intrathecally. Intrathecal injection involves administering a substance directly into the spinal canal, which requires careful selection of agents to avoid adverse reactions or toxicity.

**Why the Correct Answer is Right**
Gadolinium-based contrast agents (GBCAs) are commonly used in magnetic resonance imaging (MRI). However, only a specific subgroup of GBCAs, known as gadolinium-based myelography agents, are designed for intrathecal use. These agents are formulated to remain within the cerebrospinal fluid (CSF) for an extended period, allowing for visualization of the spinal canal and surrounding structures. The correct answer refers to this subgroup of GBCAs.

**Why Each Wrong Option is Incorrect**
* **Option A:** Iodinated contrast agents are commonly used in computed tomography (CT) scans and are not suitable for intrathecal injection due to their potential to cause neurotoxicity and inflammation in the CSF.
* **Option B:** Barium sulfate is a contrast agent used in gastrointestinal imaging and is not intended for intrathecal use, as it can cause severe inflammation and damage to the spinal cord and surrounding tissues.
* **Option C:** Ferumoxytol is an iron oxide nanoparticle used as an intravenous contrast agent for MRI, but it is not designed for intrathecal injection and can cause severe adverse reactions if administered into the spinal canal.

**Clinical Pearl / High-Yield Fact**
When administering contrast agents, it is essential to carefully consider the route of administration, the specific agent used, and the patient's underlying medical conditions to minimize the risk of adverse reactions.

**Correct Answer: C. Gadolinium-based myelography agents.**